with glandular disease [1]. When compared with omeprazole; esomeprazole, the S-enantiomer of omeprazole, has a lower first-pass hepatic metabolism, slower plasma clearance, higher peak plasma concentration, higher area under the plasma concentration-time curve and greater clinical efficacy in man. In horses, esomeprazole suppresses gastric acid production for longer than omeprazole [2]; however, efficacy in clinical cases has not been reported.
Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. E-mail: r.m.a.c.houben@uu.nl Reasons for performing study: Heart rate variability (HRV) is a popular method for assessment of equine welfare, fitness or disease state. Insufficient information on HRV test-retest reliability in horses is currently available. In humans, a supine posture minimises intraindividual variability of HRV. Whether the same applies to horses is unknown.
Objectives: To estimate the test-retest reliability of short-term HRV and to evaluate whether intra-individual variability is reduced in recumbent horses.
Study design: Validation study.
Methods: Nine healthy adult horses were fitted with a Holter monitor and left overnight in their usual surroundings while under concurrent video registration. This procedure was repeated two to six times per horse for a total of 26 recording sessions. Five min segments of electrocardiogram corresponding to postures of upright standing, sternal recumbency and lateral recumbency were selected from the continuous recordings. R-R interval series were then extracted of the selected segments for calculation of s.d. of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD), total power (TP) and low over high frequency power ratio (LF/HF). Spectral density was estimated from a Lomb-Scargle periodogram. Intraclass correlation coefficients (ICCs) and their 95% confidence intervals (CI) were computed. Conclusions: Reliability of short-term HRV parameters in standing horses was fair to poor in our study. Reliability was lowest for LF/HF. In recumbent horses, HRV reliability may be higher but this effect does not appear to be consistent for all HRV parameters. Reasons for performing study: Equine influenza vaccination (EIV) can limit disease and improve welfare in horses, so monitoring the current vaccination rate in the UK and understanding why horse-owners fail to vaccinate is important.
Results
Objectives: To assess the influenza vaccination rate and explore factors that influence whether horses in the UK are vaccinated against equine influenza.
Study design: Cross-sectional, observational survey.
Methods: A mixed-method directional survey was designed. Each participant was asked a total of 29 questions with anonymised data collected for up to five horses per participant. The survey was released online on 5 July 2016, distributed via a number of media outlets and closed on 19 October 2016. Statistical analysis included logistic regression, and Yates' chi-squared and Mann-Whitney U tests; P≤0.05 was considered significant. Thematic analysis was used to interpret the qualitative data.
Results: Responses from 4837 horse-owners who were responsible for 10,501 horses were analysed. An overall EIV vaccination rate of 80% (8385/10,501) was found. Several factors were associated significantly with lower EIV rates including: owning more than five horses; living in Wales; annual household income <£15,000; and horses never leaving home premises. Horse welfare and competition requirements were the main reasons for vaccinating against equine influenza. Several reasons for nonvaccination were identified including: not competing in affiliated competition; lack of exposure to new horses; adverse reactions to vaccines; and financial constraints. Study design: Cross-sectional study.
Methods: Tracheal wash samples submitted to Rossdales LLP for analysis from 2013 to 2015 were evaluated using set criteria. Neutrophilia and degenerate neutrophilia were analysed in relation to bacterial culture and a bacterial subset considered potentially 'pathogenic' in respiratory disease. Age as a variable was further analysed, those ≥1 to ≤4 years of age were categorised as 'young' and those >7 years as 'old'. Data were analysed using chi-squared/Fisher's exact test and univariable logistic regression where appropriate.
Results: A total of 1977 tracheal wash samples were included. Neutrophilia was significantly associated with growth of any bacteria (P<0.001, odds ratio [OR] 1.8, 95% confidence interval [CI] 1.5-2.2)) and 'pathogenic' bacteria (P<0.001, OR 3.2, 95% CI 2.5-4.2). Degenerate neutrophilia and Streptococcus zooepidemicus OR 7.9 (95% CI 5.7-11.0) or Streptococcus pneumonia OR 8.4 (95% CI 4.0-17.7) held the strongest relationships. There was no significant difference between the age groups and presence of neutrophilia (P = 0.19). 'Young' horses were significantly more likely to have degenerate neutrophilia (P<0.001) and isolate a 'pathogenic' bacterium (P<0.001, OR 7.4, 95% CI 5.2-10.6).
Conclusions: Cytological evaluation of tracheal washes should include cytomorphological features of the neutrophil response. The presence of degenerate neutrophils, especially in 'young' horses, suggests recommendation of culture and sensitivity for targeted therapeutics. Reasons for performing study: Periorbital sarcoids are a common condition in the horse, and are difficult to treat because of their location and frequently invasive and extensive nature. Radiotherapy is widely considered to be the gold standard for treatment of these lesions, which has traditionally been performed via low dose rate interstitial brachytherapy using iridium-192 wires or seeds. This technique presents many practical and health and safety challenges. High dose rate brachytherapy (HDRB) may represent a safer and more effective method of delivering radiotherapy in the standing sedated horse.
Objectives: To describe the response rate and safety of HDRB for the treatment of periorbital sarcoids in the horse.
Study design: Retrospective clinical case series.
Methods: Horses and ponies referred for HDRB treatment of histologically confirmed periorbital sarcoids were included in the study, and were treated with HDRB, which was delivered understanding sedation.
Results: In total 25 confirmed periorbital sarcoids were included in the study and 96% of lesions were successfully treated according to the cRECIST v1.0 criteria [1] . No significant acute adverse effects were noted after treatment and the cosmetic result was excellent.
Conclusions: HDRB appears to be an effective and safe method of treating periorbital sarcoids in the horse. Long-term follow-up is required to determine the recurrence rate of treated lesions and the risk of late side effects.
